The Multicenter Uveitis Steroid Treatment Trial: Rationale, Design, and Baseline Characteristics

The Multicenter Uveitis Steroid Treatment Trial Research Group,

doi:10.1016/j.ajo.2009.11.019

« Previous Next »American Journal of Ophthalmology
Volume 149, Issue 4 , Pages 550-561.e10, April 2010

The Multicenter Uveitis Steroid Treatment Trial: Rationale, Design, and Baseline Characteristics

The Multicenter Uveitis Steroid Treatment Trial Research Group
- Ocular Inflammation Service, Department of Ophthalmology/Scheie Eye Institute, University of Pennsylvania, Philadelphia, Pennsylvania
- Center for Preventive Ophthalmology and Biostatistics, Department of Ophthalmology/Scheie Eye Institute, University of Pennsylvania, Philadelphia, Pennsylvania
- Center for Clinical Epidemiology and Biostatistics, Department of Biostatistics and Epidemiology, University of Pennsylvania, Philadelphia, Pennsylvania
- Fundus Photograph Reading Center, Department of Ophthalmology, University of Wisconsin, Madison, Wisconsin
- Center for Clinical Trials, The Johns Hopkins University Bloomberg School of Public Health, Baltimore, Maryland
- Department of Epidemiology, The Johns Hopkins University Bloomberg School of Public Health, Baltimore, Maryland
- Department of Biostatistics, The Johns Hopkins University Bloomberg School of Public Health, Baltimore, Maryland
- Departments of Ophthalmology and Medicine, The Mount Sinai School of Medicine, New York, New York
- Inquiries to John H. Kempen, Center for Preventive Ophthalmology and Biostatistics, Department of Ophthalmology, University of Pennsylvania, 3535 Market Street, Suite 700, Philadelphia, PA 19104; e-mail: john.kempen@uphs.upenn.edu
- Douglas A. Jabs, MUST Chairman's Office, Department of Ophthalmology, Mount Sinai School of Medicine, One Gustave L. Levy Place, Box 1183, New York, NY 10029-6574; e-mail: douglas.jabs@mssm.edu
- Writing Committee: John H. Kempen, Michael M. Altaweel, Janet T. Holbrook, Douglas A. Jabs, and Elizabeth A. Sugar.